SETH LERNER to Fenretinide
This is a "connection" page, showing publications SETH LERNER has written about Fenretinide.
Connection Strength
0.087
-
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9.
Score: 0.077
-
Retinoids in the chemoprevention of bladder cancer. Curr Opin Oncol. 1998 Sep; 10(5):479-84.
Score: 0.010